Browse the complete record of transactions filed by Gurrola Sandra M, 董事长兼首席执行官. Officer active across 1 company, notably Brooklyn ImmunoTherapeutics, Inc.. Cumulatively, 1 disclosures have been published. Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Sandra M. Gurrola serves as the Chief Executive Officer and Vice President of Finance at Brooklyn ImmunoTherapeutics, Inc. In this role, she oversees the company's operations and financial strategy. Brooklyn ImmunoTherapeutics, Inc. specializes in developing immunotherapeutic treatments. Sandra leverages her expertise to guide the company towards sustainable growth.